European agency highlights blood clot risks from Pfizer’s arthritis drugBlood Clots, Bowel disorders, Deep Veins, European Medicines Agency, Lungs, Rheumatoid ArthritisPfizer Inc.’s rheumatoid arthritis drug Xeljanz could increase the risk of blood clots in the lungs and in deep veins, the European Medicines Agency (EMA) said. Read more October 31, 2019/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2019-10-31 11:52:292019-10-31 13:55:41European agency highlights blood clot risks from Pfizer’s arthritis drug
